Dividend Aristocrats Fortify SCHD's Income Stream This Year

The Schwab U.S. Dividend Equity ETF (SCHD) consistently offers a stable income stream through its portfolio of roughly 100 meticulously selected U.S. dividend stocks. The fund, managing $71.6 billion in assets with an incredibly low expense ratio of just 0.06%, adheres to the Dow Jones U.S. Dividend 100 Index. This index mandates that companies must have a track record of at least 10 consecutive years of dividend payments and undergo rigorous screening based on metrics such as cash flow to debt, return on equity (ROE), dividend yield, and dividend growth. This strict selection process is fundamental to safeguarding the reliability of SCHD's dividend payouts.

SCHD's impressive yield is derived directly from the regular dividends distributed by its constituent companies. The top ten holdings within the fund each represent close to 4% of total assets, collectively forming approximately 41% of the entire portfolio. Annual rebalancing, which occurs every March, ensures that the current selection of stocks remains robust and aligned with the fund's criteria. As of the December 31, 2025 fact sheet, these primary holdings include Bristol-Myers Squibb, Merck, ConocoPhillips, Lockheed Martin, Chevron, Verizon, AbbVie, Cisco, Coca-Cola, and Altria. Among these, six companies are particularly vital in reinforcing the fund's dividend security.

Examining some of SCHD's leading investments reveals the resilience underpinning its dividend strategy. AbbVie, constituting 3.99% of the fund, demonstrated a 12% revenue increase in Q1 2026, with its key product Skyrizi growing by 31%. The company has also raised its full-year adjusted EPS guidance and increased its quarterly dividend for the fifth consecutive year, indicating strong financial health despite the erosion of its Humira patent. Coca-Cola stands as a prime example of a dividend aristocrat, having expanded its operating margin to 35% in Q1 2026 and experiencing a 132% surge in free cash flow. With its 63rd consecutive annual dividend increase, the company's payout is exceptionally secure. Chevron maintains a $1.78 quarterly dividend, yielding close to 4.2%. Although its Q1 free cash flow was negative due to timing issues, its strong full-year FCF of $16.6 billion in 2025 and 39-year dividend increase streak highlight its commitment to shareholder returns. Lockheed Martin, while having a tight Q1 free cash flow, reaffirmed robust full-year FCF guidance and boosted its dividend by 5%, marking its 23rd consecutive increase. Verizon offers an attractive yield of around 6.5%. Despite increased debt from the Frontier deal, its 2025 free cash flow comfortably covered its $11.5 billion dividend, and 2026 forecasts project even stronger cash generation. Merck, despite reporting a GAAP loss in Q1 due to an acquisition charge, saw its crucial drug KEYTRUDA grow by 12%, and its operational cash flow continues to support its quarterly dividend.

SCHD has delivered impressive returns, with a 20% gain year-to-date and 23% over the past year, culminating in a 227% return over a decade. The fund's income stability is rooted in companies with strong cash flow generation, and its annual rebalancing mechanism ensures that only companies with sustained dividend growth remain in the portfolio. For investors who prioritize both growth and reliable income, SCHD offers a secure distribution. While aggressive investors might seek higher yields from options-based funds, and growth-focused dividend investors might prefer ETFs with faster payout growth, SCHD stands out for its balanced approach, providing a steady and secure income stream supported by financially sound companies.